Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino Ethyl)pyridine, Dihydrochloride
2. Cp 24315-1
3. Cp-24,314-1
4. Cp-24315-1
5. Maxair
6. Pirbuterol
7. Pirbuterol Acetate Salt
8. Pirbuterol Dihydrochloride
9. Pirbuterol Sulfate
10. Pyrbuterol
1. 65652-44-0
2. Maxair
3. Pirbuterol Acetate [usan]
4. Spirolair
5. Pirbuterol Monoacetate
6. Cp-24,314-14
7. 1eh73xkr9n
8. 65652-44-0 (acetate)
9. 2-(hydroxymethyl)-6-(1-hydroxy-2-tert-butylamino-ethyl)-pyridin-3-ol
10. Cp 24314-14; Maxair;spirolair
11. Cp-24314-14
12. Pirbuterol Acetate (usan)
13. Acetic Acid;6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
14. 6-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)pyridin-3-ol; Acetic Acid
15. Einecs 265-862-4
16. Unii-1eh73xkr9n
17. Maxair (tn)
18. Schembl3600
19. Alpha(sup 6)-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)
20. Chebi:8246
21. Chembl1200444
22. Dtxsid40984214
23. Pirbuterol Acetate [vandf]
24. Pirbuterol Acetate [mart.]
25. Pirbuterol Monoacetate [mi]
26. Pirbuterol Acetate [who-dd]
27. Alpha6-((tert-butylamino)methyl)-3-hydroxypyridine-2,6-dimethanol Monoacetate
28. Pirbuterol Acetate [orange Book]
29. 2,6-pyridinedimethanol, Alpha(sup 6)-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)
30. D00686
31. Pirbuterol Acetate 100 Microg/ml In Acetonitrile
32. Pirbuterol Acetate, Vetranal(tm), Analytical Standard
33. Q27252326
34. Pirbuterol Acetate, United States Pharmacopeia (usp) Reference Standard
35. Acetic Acid--6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol (1/1)
36. .alpha.6-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)
37. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Acetate (1:1)
38. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)
Molecular Weight | 300.35 g/mol |
---|---|
Molecular Formula | C14H24N2O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 300.16852187 g/mol |
Monoisotopic Mass | 300.16852187 g/mol |
Topological Polar Surface Area | 123 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 261 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Maxair |
PubMed Health | Pirbuterol (By breathing) |
Drug Classes | Bronchodilator |
Drug Label | The active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace... |
Active Ingredient | Pirbuterol acetate |
Dosage Form | Aerosol, metered |
Route | Inhalation |
Strength | eq 0.2mg base/inh |
Market Status | Prescription |
Company | Medicis |
2 of 2 | |
---|---|
Drug Name | Maxair |
PubMed Health | Pirbuterol (By breathing) |
Drug Classes | Bronchodilator |
Drug Label | The active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace... |
Active Ingredient | Pirbuterol acetate |
Dosage Form | Aerosol, metered |
Route | Inhalation |
Strength | eq 0.2mg base/inh |
Market Status | Prescription |
Company | Medicis |
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of PIRBUTEROL ACETATE API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right PIRBUTEROL ACETATE manufacturer or PIRBUTEROL ACETATE supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred PIRBUTEROL ACETATE manufacturer or PIRBUTEROL ACETATE supplier.
PharmaCompass also assists you with knowing the PIRBUTEROL ACETATE API Price utilized in the formulation of products. PIRBUTEROL ACETATE API Price is not always fixed or binding as the PIRBUTEROL ACETATE Price is obtained through a variety of data sources. The PIRBUTEROL ACETATE Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PIRBUTEROL ACETATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PIRBUTEROL ACETATE, including repackagers and relabelers. The FDA regulates PIRBUTEROL ACETATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PIRBUTEROL ACETATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PIRBUTEROL ACETATE supplier is an individual or a company that provides PIRBUTEROL ACETATE active pharmaceutical ingredient (API) or PIRBUTEROL ACETATE finished formulations upon request. The PIRBUTEROL ACETATE suppliers may include PIRBUTEROL ACETATE API manufacturers, exporters, distributors and traders.
click here to find a list of PIRBUTEROL ACETATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PIRBUTEROL ACETATE DMF (Drug Master File) is a document detailing the whole manufacturing process of PIRBUTEROL ACETATE active pharmaceutical ingredient (API) in detail. Different forms of PIRBUTEROL ACETATE DMFs exist exist since differing nations have different regulations, such as PIRBUTEROL ACETATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PIRBUTEROL ACETATE DMF submitted to regulatory agencies in the US is known as a USDMF. PIRBUTEROL ACETATE USDMF includes data on PIRBUTEROL ACETATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PIRBUTEROL ACETATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PIRBUTEROL ACETATE suppliers with USDMF on PharmaCompass.
PIRBUTEROL ACETATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PIRBUTEROL ACETATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PIRBUTEROL ACETATE GMP manufacturer or PIRBUTEROL ACETATE GMP API supplier for your needs.
A PIRBUTEROL ACETATE CoA (Certificate of Analysis) is a formal document that attests to PIRBUTEROL ACETATE's compliance with PIRBUTEROL ACETATE specifications and serves as a tool for batch-level quality control.
PIRBUTEROL ACETATE CoA mostly includes findings from lab analyses of a specific batch. For each PIRBUTEROL ACETATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PIRBUTEROL ACETATE may be tested according to a variety of international standards, such as European Pharmacopoeia (PIRBUTEROL ACETATE EP), PIRBUTEROL ACETATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PIRBUTEROL ACETATE USP).